Hang Guo

Beijing, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

Dapagliflozin to Reduce Early Recurrence After Catheter Ablation for Atrial Fibrillation: The DARE-AF Randomized Clinical Trial.

Dapagliflozin to Reduce Early Recurrence After Catheter Ablation for Atrial Fibrillation: The DARE-AF Randomized Clinical Trial.

Journal: Circulation

Published: November 09, 2025

Impact of Sodium-Glucose Cotransporter 2 Inhibitor on Recurrence After Catheter Ablation for Atrial Fibrillation in Patients With or Without Metabolic Syndrome.

Impact of Sodium-Glucose Cotransporter 2 Inhibitor on Recurrence After Catheter Ablation for Atrial Fibrillation in Patients With or Without Metabolic Syndrome.

Journal: Journal of cardiovascular electrophysiology

Published: June 12, 2025

Impact of sodium-glucose cotransporter 2 inhibitors on recurrence and cardiovascular outcomes after catheter ablation for atrial fibrillation in patients with chronic kidney disease.

Impact of sodium-glucose cotransporter 2 inhibitors on recurrence and cardiovascular outcomes after catheter ablation for atrial fibrillation in patients with chronic kidney disease.

Journal: Heart rhythm

Published: June 05, 2025

Impact of disease progression avoidance by catheter ablation on clinical outcomes in atrial fibrillation: Insights from the CABANA trial.

Impact of disease progression avoidance by catheter ablation on clinical outcomes in atrial fibrillation: Insights from the CABANA trial.

Journal: Heart rhythm

Published: April 14, 2025

Impact of atrial remodeling on efficacy of catheter ablation in reducing cardiovascular risk in atrial fibrillation: Results from CABANA trial.

Impact of atrial remodeling on efficacy of catheter ablation in reducing cardiovascular risk in atrial fibrillation: Results from CABANA trial.

Journal: Heart rhythm

Published: January 08, 2025

Non-early catheter ablation vs drug therapy in atrial fibrillation: Results from the CABANA trial.

Non-early catheter ablation vs drug therapy in atrial fibrillation: Results from the CABANA trial.

Journal: Heart rhythm

Published: September 14, 2024

Impact of sodium-glucose cotransporter 2 inhibitor on recurrence and cardiovascular outcomes after catheter ablation for atrial fibrillation in patients with heart failure.

Impact of sodium-glucose cotransporter 2 inhibitor on recurrence and cardiovascular outcomes after catheter ablation for atrial fibrillation in patients with heart failure.

Journal: Heart rhythm

Published: May 15, 2024

Association between the preprocedural serum potassium level and atrial fibrillation recurrence after catheter ablation.

Association between the preprocedural serum potassium level and atrial fibrillation recurrence after catheter ablation.

Journal: Heart rhythm

Published: March 06, 2024

Orthostatic blood pressure changes do not influence cognitive outcomes following intensive blood pressure control.

Orthostatic blood pressure changes do not influence cognitive outcomes following intensive blood pressure control.

Journal: Journal of internal medicine

Published: December 19, 2023

Association between the ZJU index and risk of new-onset non-alcoholic fatty liver disease in non-obese participants: a Chinese longitudinal prospective cohort study.

Association between the ZJU index and risk of new-onset non-alcoholic fatty liver disease in non-obese participants: a Chinese longitudinal prospective cohort study.

Journal: Frontiers in endocrinology

Published: November 18, 2023

Effect of visit-to-visit blood pressure variability on mild cognitive impairment and probable dementia in hypertensive patients receiving standard and intensive blood pressure treatment.

Effect of visit-to-visit blood pressure variability on mild cognitive impairment and probable dementia in hypertensive patients receiving standard and intensive blood pressure treatment.

Journal: Frontiers in cardiovascular medicine

Published: February 15, 2023

Weight cycling and risk of clinical adverse events in patients with heart failure with preserved ejection fraction: a post-hoc analysis of TOPCAT.

Weight cycling and risk of clinical adverse events in patients with heart failure with preserved ejection fraction: a post-hoc analysis of TOPCAT.

Journal: Frontiers in endocrinology

Published: February 06, 2023

Showing 1-12 of 13

Last Updated: 09/26/2026